Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma, among non-Hodgkin lymphomas, is one of the most frequent subtypes. Clinical laboratory data and post-treatment outcomes are scarce in the Brazilian population. OBJECTIVE: The main objective of this retrospective study was to assess the impact of tumor marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogliatto, Laura, Grokoski, Kamila Castro, Strey, Yuri Machado, Vanelli, Tito, Fraga, Christina Garcia da Silva, Barra, Marines Bizarro, Pinto, Fernanda Correa, Bendit, Israel, Bica, Claúdia Giuliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371411/
https://www.ncbi.nlm.nih.gov/pubmed/30793105
http://dx.doi.org/10.1016/j.htct.2018.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371411/
https://www.ncbi.nlm.nih.gov/pubmed/30793105
http://dx.doi.org/10.1016/j.htct.2018.05.014

Ejemplares similares